Cresco Labs Inc.
CL
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -8.16% | -8.27% | -11.14% | -10.15% | -4.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.16% | -8.27% | -11.14% | -10.15% | -4.92% |
| Cost of Revenue | -14.86% | -0.92% | -10.28% | -5.38% | -0.23% |
| Gross Profit | -0.84% | -15.07% | -11.93% | -15.05% | -9.57% |
| SG&A Expenses | 2.14% | -9.38% | -6.48% | 4.28% | 10.60% |
| Depreciation & Amortization | -9.00% | -1.16% | -14.82% | -4.91% | -45.31% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.23% | -4.24% | -8.96% | -1.88% | 0.61% |
| Operating Income | -7.63% | -29.55% | -21.53% | -53.40% | -34.11% |
| Income Before Tax | -2,952.60% | -189.22% | 106.70% | -105.76% | -76.17% |
| Income Tax Expenses | -31.12% | -37.59% | 62.50% | -20.48% | -67.09% |
| Earnings from Continuing Operations | -20,361.73% | -185.52% | 72.85% | -641.31% | -90.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 128.29% | 272.60% | 22.58% | 125.56% | -115.45% |
| Net Income | -1,903.39% | -61.79% | 69.94% | -177.91% | -265.92% |
| EBIT | -7.63% | -29.55% | -21.53% | -53.40% | -34.11% |
| EBITDA | -13.89% | -24.19% | -20.53% | -40.45% | -32.99% |
| EPS Basic | -1,831.75% | -58.42% | 70.73% | -171.05% | -261.54% |
| Normalized Basic EPS | 361.54% | 88.62% | 118.88% | -94.95% | -146.43% |
| EPS Diluted | -1,831.75% | -58.42% | 70.73% | -171.05% | -261.54% |
| Normalized Diluted EPS | 361.54% | 88.62% | 118.88% | -94.95% | -146.43% |
| Average Basic Shares Outstanding | 3.44% | 2.35% | 2.72% | 2.52% | 2.60% |
| Average Diluted Shares Outstanding | 3.44% | 2.35% | 2.72% | 2.52% | 2.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |